Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Yunmi Ko"'
Autor:
Jeayeon Park, Yun Bin Lee, Yunmi Ko, Youngsu Park, Hyunjae Shin, Moon Haeng Hur, Min Kyung Park, Dae-Won Lee, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Tae-Yong Kim, Yoon Jun Kim, Tae-You Kim, Jung-Hwan Yoon
Publikováno v:
Journal of Liver Cancer, Vol 24, Iss 1, Pp 81-91 (2024)
Background/Aim Atezolizumab plus bevacizumab and lenvatinib are currently available as first-line therapy for the treatment of unresectable hepatocellular carcinoma (HCC). However, comparative efficacy studies are still limited. This study aimed to i
Externí odkaz:
https://doaj.org/article/0fba6f18253441e3be10280165c026e9
Autor:
Hyunjae Shin, Won-Mook Choi, Seung Up Kim, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Fabien Zoulim
Publikováno v:
JHEP Reports, Vol 6, Iss 7, Pp 101089- (2024)
Background & Aims: The association between hepatitis B envelope antigen (HBeAg) seroclearance during long-term nucleos(t)ide analogue (NA) treatment and the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) remains unc
Externí odkaz:
https://doaj.org/article/fc34919f2cb14440bf605509859aac29
Publikováno v:
Cells, Vol 11, Iss 14, p 2164 (2022)
Immunotherapy is an attractive therapeutic strategy for the treatment of osteosarcoma (OS). The unique features of γδ T cells have made them popular for cancer immunotherapy. Here, we expanded γδ T cells using human peripheral blood mononuclear c
Externí odkaz:
https://doaj.org/article/81bc9fb0b571470cbcc720fe980c2b4a
Publikováno v:
Korean Journal of Pediatrics, Vol 59, Iss 9, Pp 374-380 (2016)
PurposePatients with unresectable, relapsed, or refractory osteosarcoma need a novel therapeutic agent. Metformin is a biguanide derivative used in the treatment of type II diabetes, and is recently gaining attention in cancer research.MethodsWe eval
Externí odkaz:
https://doaj.org/article/b6cacd2623da4c119d783f89c9ab0576
Publikováno v:
Cells; Volume 11; Issue 14; Pages: 2164
Immunotherapy is an attractive therapeutic strategy for the treatment of osteosarcoma (OS). The unique features of γδ T cells have made them popular for cancer immunotherapy. Here, we expanded γδ T cells using human peripheral blood mononuclear c
Publikováno v:
In Vivo
Background/aim Osteosarcoma is the most common type of bone cancer, but current therapeutic interventions remain largely insufficient. The development of new treatment strategies is needed, and moreover, optimal rodent models are necessary for testin
Publikováno v:
Clinical Pediatric Hematology-Oncology. 25:50-55
Autor:
Yunmi Ko
Publikováno v:
ICE/ITMC
The private sector is considered as a core driver of national innovation activities. From the perspective of national innovation system, it is the key sub-system in which various innovation activities are triggered by profit maximization motives. Cur
Autor:
Young Kyung Kang, Jun Ah Lee, Hyeong Jwa Choi, Min Young Lee, Aery Choi, Yunmi Ko, Jin-Hee Seo
Publikováno v:
Blood research
Background Humanized mouse models are still under development, and various protocols exist to improve human cell engraftment and function. Methods Fourteen NOD/SCID/IL-2Rγnull (NSG) mice (4‒5 wk old) were conditioned with busulfan and injected wit
Publikováno v:
In Vivo; Jul/Aug2021, Vol. 35 Issue 4, p2151-2157, 7p